Dae Han New Pharm Co., Ltd. operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Dae Han New Pharm Co., Ltd. with three other
companies in this sector in South Korea:
Celltrion Pharm Incorporated
sales of 135.86 billion Korean Won [US$119.83 million]
of which 100%
Hyundai Pharmaceutical Company Limited
(130.48 billion Korean Won [US$115.08 million]
of which 88%
was Pharmaceutical), and
Reyon Pharmaceutical Co Ltd
(126.25 billion Korean Won [US$111.36 million]
Dae Han New Pharm Co., Ltd. reported sales of 130.82 billion Korean Won (US$115.38 million)
December of 2017.
increase of 19.6%
versus 2016, when the company's sales were 109.40 billion Korean Won.
Sales at Dae Han New Pharm Co., Ltd. have increased during each of the previous five years
(and since 2012, sales have increased a total of 172%).